Comment on "Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment" by Yap et al.
Kwan
J T
JT
Cunningham
J
J
D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D000077268:Pamidronate; D006435:Renal Dialysis
D004164:Diphosphonates; D000077268:Pamidronate